These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6121440)

  • 1. Further clinical experience with oxyprothepin-decanoate.
    Kalvach Z; Hálková E; Bastecký J
    Act Nerv Super (Praha); 1981 Dec; 23(4):271-2. PubMed ID: 6121440
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of oxyprothepin decanoate (author's transl)].
    Kabes J; Balon R; Hanzlícek L; Skovajsová M; Kozáková H
    Cesk Psychiatr; 1980 Feb; 76(1):16-25. PubMed ID: 6103755
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study].
    Filip V; Faltus F; Hanáková S; Janecková E; Raboch J; Dobiásová A; Karen P; Posmurová M
    Cesk Psychiatr; 1985 Feb; 81(1):6-14. PubMed ID: 2858269
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R; Kabesh Ia; Papezhova G
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Our first experimental and clinical experience with the neuroleptic isofloxythepin].
    Náhunek K; Svestka J; Cesková E; Rysánek R
    Cesk Psychiatr; 1984 Aug; 80(4):220-3. PubMed ID: 6149815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Substitution of fluphenazine decanoate with oxyprothepine decanoate in long-term maintenance therapy in schizophrenia].
    David I; Filip V; Hellerová P
    Cesk Psychiatr; 1986 Oct; 82(5):313-7. PubMed ID: 2878734
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses].
    Cesková E; Svestka J; Rysánek R
    Cesk Psychiatr; 1993 Jan; 89(1):11-4. PubMed ID: 8099534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isofloxythepine in an open study.
    Papezová H; David I; Alda M; Soucek R
    Act Nerv Super (Praha); 1989 Jun; 31(2):121-2. PubMed ID: 2572133
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical effectiveness of isofloxythepin--an open study].
    Zapletálek M; Tůma I; Kudrnová K
    Cesk Psychiatr; 1985 Aug; 81(4):242-6. PubMed ID: 2864141
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of maintenance therapy with oxyprothepin decanoate in schizophrenics: open study.
    Svestka J; Náhunek K; Cesková E; Rysánek R
    Act Nerv Super (Praha); 1979 Oct; 21(3):138-9. PubMed ID: 42261
    [No Abstract]   [Full Text] [Related]  

  • 11. Oxyprothepin and clorotepin compared in the hyperkinetic syndrome.
    Výborová L; Náhunek K; Drtilková I; Balastíková B
    Act Nerv Super (Praha); 1989 Apr; 31(1):45-6. PubMed ID: 2571227
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxyprothepin decanoat injections: experience with a long-term treatment of schizophrenic psychoses.
    Zapletálek M; Zbytovský J; Kindernayová H; Svejkovská J
    Act Nerv Super (Praha); 1979 Oct; 21(3):138. PubMed ID: 42260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Zotepin--its value and potentials for further development].
    Nervenarzt; 1994 Jul; 65(7 Suppl):1-8. PubMed ID: 9218060
    [No Abstract]   [Full Text] [Related]  

  • 15. Visual evoked potentials during the treatment with isofloxythepine.
    Libiger J; Kuba M; Zapletálek M; Dostál J
    Act Nerv Super (Praha); 1989 Apr; 31(1):34-5. PubMed ID: 2571219
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical comparison of oxyprothepin and clotepine in schizophrenic patients (controlled study).
    Náhunek K; Svestka J; Cesková E; Rysánek R
    Act Nerv Super (Praha); 1979 Oct; 21(3):133-5. PubMed ID: 42259
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled comparison of therapeutic effects of oxyprothepin and chlorpromazine in schizophrenic patients [proceedings].
    Vinar O; Taussigová D; Bastecký J; Vinarová E
    Act Nerv Super (Praha); 1976; 18(3):212-4. PubMed ID: 12642
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.
    Hashimoto K; Sudo T; Hirano M; Motomura H; Tagawa K; Nashiro S; Uemura K; Yoshimoto S
    Schizophr Res; 2006 Oct; 87(1-3):332-3. PubMed ID: 16797164
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Experience with oxyprothepin in the treatment of endogenous depression.
    Náhunek K; Svestka J; Rodová A; Cesková E; Kulísková O
    Act Nerv Super (Praha); 1975; 17(4):211-2. PubMed ID: 1221758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.